Vol 5, No 2 (2020)
Letter to the Editor
Published online: 2020-04-03

open access

Page views 2248
Article views/downloads 1598
Get Citation

Connect on Social Media

Connect on Social Media

The content of this article is also available in the following languages:

The COVID-19 pandemic — a view of the current state of the problem

Kurt Ruetzler1, Lukasz Szarpak23, Krzysztof Jerzy Filipiak4, Jerzy Robert Ladny53, Jacek Smereka63
Disaster Emerg Med J 2020;5(2):106-107.


The current pandemic has raised great global public health concern. The disease name was subsequently recommended as COVID-19 by the World Health Organisation (WHO) [1,2]. Meanwhile, 2019-nCoV was renamed SARS-CoV-2 by the International Committee on Taxonomy of Viruses. SARS CoV-2 is considered highly contagious. As of April 1, 2020, more than 883,255 confirmed cases, including more than 44,156 deaths, have been reported worldwide, affecting almost the whole world.

Article available in PDF format

View PDF Download PDF file


  1. Guan WJ, Ni ZY, Hu Yu, et al. China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020 [Epub ahead of print].
  2. Zhu Na, Zhang D, Wang W, et al. China Novel Coronavirus Investigating and Research Team. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020; 382(8): 727–733.
  3. Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, et al. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect Dis. 2013; 13(9): 752–761.
  4. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet. 2020; 395(10223): 507–513.
  5. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020; 395(10223): 497–506.
  6. Xu XW, Wu XX, Jiang XG, et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ. 2020; 368: m606.
  7. Wang D, Hu Bo, Hu C, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020 [Epub ahead of print].
  8. Liu M, He P, Liu HG, et al. [Clinical characteristics of 30 medical workers infected with new coronavirus pneumonia]. Zhonghua Jie He He Hu Xi Za Zhi. 2020; 43(3): 209–214.
  9. Yuan M, Yin W, Tao Z, et al. Association of radiologic findings with mortality of patients infected with 2019 novel coronavirus in Wuhan, China. PLoS One. 2020; 15(3): e0230548.
  10. Chen J, Qi T, Liu Li, et al. Clinical progression of patients with COVID-19 in Shanghai, China. J Infect. 2020 [Epub ahead of print].
  11. Mo P, Xing Y, Xiao Yu, et al. Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China. Clin Infect Dis. 2020 [Epub ahead of print].
  12. Qian GQ, Yang NB, Ding F, et al. Epidemiologic and Clinical Characteristics of 91 Hospitalized Patients with COVID-19 in Zhejiang, China: A retrospective, multi-centre case series. QJM. 2020 [Epub ahead of print].
  13. Smereka J, Szarpak L. COVID 19 a challenge for emergency medicine and every health care professional. The American Journal of Emergency Medicine. 2020.
  14. Smereka J, Szarpak L, Filipiak KJ. Modern medicine in COVID-19 er. Disster Emerg Med J 2020. Doi: 10 5603/DEMJ a. 2020; 0012.